Author
Listed:
- Julien Lafrance-Vanasse
(Inc.)
- Shraddha S. Sadekar
(Inc.)
- Yanli Yang
(Inc.)
- Daniela Bumbaca Yadav
(Inc.)
- William J. Meilandt
(Inc.)
- Monica K. Wetzel-Smith
(Inc.)
- Hao Cai
(Inc.)
- Susan R. Crowell
(Inc.)
- Van Nguyen
(Inc.)
- Vivian Lee
(Inc.)
- Ben Chih
(Inc.)
- Mandy Kwong
(Inc.)
- Pamela Chan
(Inc.)
- Sara Santagostino
(Inc.)
- Donna Lee
(Inc.)
- Shan Chung
(Inc.)
- Greg A. Lazar
(Inc.)
- James A. Ernst
(Inc.)
- Jasvinder K. Atwal
(Inc.)
Abstract
The blood-brain barrier (BBB) restricts efficient penetration of systemically delivered therapeutic antibodies into the brain, limiting the development of this class of drugs to treat neurodegenerative diseases. Here we demonstrate that the neonatal Fc receptor (FcRn), which is highly expressed at the BBB, can be used to facilitate IgG transport to the brain. Engineering of the antibody Fc region to promote binding to FcRn at neutral pH enhances antibody transcytosis in a cellular model. In vivo, these modifications improve brain penetration, as well as brain target engagement and activity, of systemically administered antibodies in both mice and non-human primates. This engineering approach can be broadly implemented to enhance central nervous system (CNS) exposure of antibody- and Fc-based drugs, improving the clinical potential of biotherapeutics for the treatment of human brain diseases.
Suggested Citation
Julien Lafrance-Vanasse & Shraddha S. Sadekar & Yanli Yang & Daniela Bumbaca Yadav & William J. Meilandt & Monica K. Wetzel-Smith & Hao Cai & Susan R. Crowell & Van Nguyen & Vivian Lee & Ben Chih & Ma, 2025.
"Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrier,"
Nature Communications, Nature, vol. 16(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59447-1
DOI: 10.1038/s41467-025-59447-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59447-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.